Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Market Capitalization (2021 - 2026)

Invivyd's (IVVD) quarterly Market Capitalization came in at $256.4 million in Q2 2026, up 200.62% on a YoY basis from $85.3 million in Q2 2025, and down 39.71% quarter-over-quarter from $425.4 million in Q4 2025.

Analysis

Invivyd (IVVD) Market Capitalization (2021 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Market Capitalization for 6 consecutive years, with $256.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Market Capitalization rose 200.62% year-over-year to $256.4 million; the trailing twelve-month figure through Jun 2026 stood at $256.4 million (up 200.62% YoY), and the FY2025 full-year result was $425.4 million, up 706.73% from the prior year.
  • Market Capitalization eased to $256.4 million in Q2 2026 per IVVD's latest filing, from $425.4 million in the prior quarter.
  • Across five years, Market Capitalization topped out at $529.3 million in Q1 2024 and bottomed at $52.7 million in Q4 2024.
  • Historically, Market Capitalization has averaged $240.7 million across 5 years, with a median of $186.7 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Market Capitalization sank 87.85% in 2024, then surged 706.73% in 2025.
  • Over 5 years, Market Capitalization stood at $163.6 million in 2022, then jumped by 165.36% to $434.0 million in 2023, then tumbled by 87.85% to $52.7 million in 2024, then soared by 706.73% to $425.4 million in 2025, then plunged by 39.71% to $256.4 million in 2026.
  • According to Business Quant data, Market Capitalization over the past three periods registered $256.4 million, $425.4 million, and $187.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 256.44 Mn
Dec 31, 2025 425.37 Mn
Sep 30, 2025 187.19 Mn
Jun 30, 2025 85.30 Mn
Mar 31, 2025 73.18 Mn
Dec 31, 2024 52.73 Mn
Sep 30, 2024 122.00 Mn
Jun 30, 2024 131.39 Mn
Mar 31, 2024 529.34 Mn
Dec 31, 2023 434.03 Mn
Sep 30, 2023 186.74 Mn
Jun 30, 2023 115.05 Mn
Mar 31, 2023 131.18 Mn
Dec 31, 2022 163.57 Mn
Sep 30, 2022 341.04 Mn
Jun 30, 2022 356.80 Mn
Mar 31, 2022 500.12 Mn
Dec 31, 2021 309.43 Mn
Sep 30, 2021 2.59 Bn